Global Gold Nanoparticles Market

Global Gold Nanoparticles Market Size, Share, Growth Analysis, By Type(Water soluble, oil soluble and others), By Application(Medial and Dentistry, electronics) - Industry Forecast 2024-2031

Report ID: SQMIG15E2219 | Region: Global | Published Date: April, 2024
Pages: 184 | Tables: 62 | Figures: 75

Global Gold Nanoparticles Market News

  • In October 2022, Nanostellar Inc. announced a breakthrough in the production of gold nanoparticles with high crystalline purity, enabling advanced applications in electronics and catalysis.
  • In August 2022, Tanaka Holdings Co. Ltd. launched a new generation of gold nanoparticles with controlled size and shape, offering enhanced catalytic properties for use in green chemistry applications.
  • In May 2022, BBI Solutions introduced a range of gold nanoparticle-based lateral flow assays, enabling quick and reliable point-of-care testing for various medical conditions.
  • In February 2022, Nanosphere Inc. unveiled a cutting-edge diagnostic platform utilizing gold nanoparticles for rapid and accurate detection of infectious diseases.
  • In November 2021, Goldsol Inc. announced the development of a breakthrough gold nanoparticle-based cancer treatment, demonstrating promising results in preclinical trials.
  • In September 2021, Nanopartz Inc. launched a novel series of gold nanorods with improved optical properties, offering enhanced performance in imaging and sensing applications.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Gold Nanoparticles Market size was valued at USD 6.71 billion in 2022 and is poised to grow from USD 8.22 billion in 2023 to USD 41.68 billion by 2031, growing at a CAGR of 22.50% during the forecast period (2024-2031).

The global gold nanoparticles market is characterized by intense competition, primarily due to its fragmented nature. Market players are making substantial investments in research and development to broaden the range of applications for gold nanoparticles. Additionally, they are employing strategies like mergers and acquisitions, expanding their production capacities, and fostering strong relationships with local and regional distributors to enhance their market presence and capture a larger market share. 'Cytodiagnostics Inc. (Canada)', 'Goldsol Inc. (US)', 'BBI Solutions (UK)', 'NanoHybrids Inc. (US)', 'Nanopartz Inc. (US)', 'Nanosphere Inc. (US)', 'Nanostellar Inc. (US)', 'Solaris Nanosciences Corporation (US)', 'Tanaka Holdings Co. Ltd. (Japan)', 'The Metalor Group (Switzerland)', 'Sigma Aldrich (US)', 'NanoComposix (US)', 'Innova Biosciences (UK)', 'Creative Diagnostics (US)', 'Sona Nanotech Inc. (Canada)', 'Cima NanoTech (US)', 'NanoTemper Technologies (Germany)', 'NN-Labs LLC (US)', 'Meliorum Technologies Inc. (US)', 'Strem Chemicals Inc. (US)'

One key driver of the gold nanoparticles market is the increasing demand for advanced medical diagnostics and treatments. The unique properties of gold nanoparticles, such as their biocompatibility, stability, and ability to enhance imaging and targeted drug delivery, make them highly valuable in the healthcare sector. The growing need for more precise and effective diagnostic tools, coupled with advancements in medical technology, drives the demand for gold nanoparticles in medical applications.

One key market trend in the global gold nanoparticles market is the increasing adoption of gold nanoparticles in targeted drug delivery systems. Gold nanoparticles have gained significant attention for their potential in delivering therapeutic agents with high precision and efficacy. The ability of gold nanoparticles to be functionalized with specific targeting ligands allows for selective delivery of drugs to the desired site, minimizing off-target effects and improving therapeutic outcomes. This trend aligns with the growing focus on personalized medicine and the development of more targeted and effective treatment approaches.

The dominant region in the gold nanoparticles market is North America. North America has a strong presence in the market, driven by advanced healthcare infrastructure, significant investments in research and development, and a high level of adoption of technological advancements. The region is home to several key players in the gold nanoparticles industry, contributing to its dominance. Moreover, the growing demand for gold nanoparticles in medical diagnostics, targeted cancer imaging, and improved drug delivery systems, coupled with the rising disposable income and increasing awareness for advanced medical treatments, further bolster the dominance of North America in the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Cosmetics Preservative Market
Buy Now GET FREE SAMPLE
Global Technical Ceramics Market
Buy Now GET FREE SAMPLE
Emulsion Polymer Market
Buy Now GET FREE SAMPLE
High Performance Pigments Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Gold Nanoparticles Market

Product ID: SQMIG15E2219

$5,300
BUY NOW GET FREE SAMPLE